Mergers & Acquisitions

Sun Pharma to acquire 18.75% stake in Israel’s Tarsius Pharma

Opportunity India Desk
Opportunity India Desk Sep 11, 2018 - 0 min read
Sun Pharma to acquire 18.75% stake in Israel’s Tarsius Pharma image
Sun Pharmaceutical Industries Ltd will buy 18.75% stake in Israel's Tarsius Pharma Ltd for $3 million in cash.

Sun Pharmaceutical Industries Ltd, India’s biggest drugmaker, will buy 18.75% stake in Israel's Tarsius Pharma Ltd for $3 million in cash.

The company said, “One of its wholly-owned subsidiaries has agreed to acquire 3,45,622 ordinary shares of Tarsius Pharma, of nominal value of NIS 0.01 each by way of subscription, representing 18.75 per cent of shares of Tarsius on a fully diluted basis.”

"Cost of acquisition is $3 million," Sun Pharma added. 

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Franchise india Insights
The Franchising World Magazine

For hassle-free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online

Newsletter Signup

Share your email address to get latest update from the industry